Close Menu

NEW YORK — UK immunodiagnostics firm Oncimmune said today that a distribution partner for its EarlyCDT Lung cancer assay has signed a sales and marketing agreement for the test with Spanish private healthcare organization Vithas Group.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.